New imaging agent could sharpen lung cancer diagnosis
NCT ID NCT07370805
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether a new type of PET scan (18F-FAPI) can more accurately detect lung cancer and help predict patient outcomes. About 120 adults already diagnosed with lung cancer will receive the scan. The goal is to see if this imaging method is better than current techniques at finding tumors and guiding treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which lung biopsy method is safer and more accurate?
- Light-Based blood test may spot lung cancer early
- Could a nebulized cocktail make lung scopes less Cough-Inducing?
- A personalized approach to breathlessness: could a stepped-care program offer relief for lung cancer patients?
- Common mucus-thinning drugs may improve outcomes in COPD patients with lung cancer
- Can a simple blood test predict leukemia risk after cancer therapy?